Ehsan Malek
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
- Hematology 75
- Multiple Myeloma Research and Treatments 62
- Hematopoietic Stem Cell Transplantation 14
- Chronic Myeloid Leukemia Treatments 9
- Co-authors
- James J. Driscoll (46 shared papers)Sajjeev Jagannathan (6 shared papers)James J. Ignatz-Hoover (9 shared papers)Byung‐Gyu Kim (5 shared papers)Sung Hee Choi (3 shared papers)Marcos de Lima (60 shared papers)Muthulekha Swamydas (3 shared papers)Nikhil Vad (4 shared papers)
- Journals
- Blood (44 papers)Biology of Blood and Marrow Transplantation (16 papers)Journal of Clinical Oncology (9 papers)Oncotarget (4 papers)Cancer Research (3 papers)
- Partner nations
- United StatesSouth KoreaCanada
In The Last Decade
Ehsan Malek
98 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Hematology 397
- Oncology 538
- Cancer Research 261
- Immunology 245
- Molecular Biology 744
Countries citing papers authored by Ehsan Malek
This map shows the geographic impact of Ehsan Malek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Malek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Malek more than expected).
Fields of papers citing papers by Ehsan Malek
This network shows the impact of papers produced by Ehsan Malek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Malek. The network helps show where Ehsan Malek may publish in the future.
Co-authors
The 25 scholars most cited alongside Ehsan Malek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel therapies emerging in oncology to target the TGF-β pathway Hit paper breakdown → | 2021 | 288 |
| 2 | 2014 | 153 | |
| 3 | 2016 | 103 | |
| 4 | 2015 | 86 | |
| 5 | 2022 | 75 | |
| 6 | 2014 | 70 | |
| 7 | 2016 | 48 | |
| 8 | 2014 | 36 | |
| 9 | 2019 | 33 | |
| 10 | 2019 | 32 | |
| 11 | 2014 | 27 | |
| 12 | 2018 | 24 | |
| 13 | 2015 | 20 | |
| 14 | 2016 | 17 | |
| 15 | 2021 | 15 | |
| 16 | 2017 | 14 | |
| 17 | 2024 | 12 | |
| 18 | 2019 | 12 | |
| 19 | 2020 | 12 | |
| 20 | 2024 | 9 |
About Ehsan Malek
Ehsan Malek is a scholar working on Hematology, Transplantation, Oncology, Genetics and Pathology and Forensic Medicine, having authored 113 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (62 papers), Protein Degradation and Inhibitors (17 papers), Hematopoietic Stem Cell Transplantation (14 papers), Peptidase Inhibition and Analysis (13 papers), Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers), Ubiquitin and proteasome pathways (10 papers) and Chronic Myeloid Leukemia Treatments (9 papers). The work is most often cited by research in Hematology (397 citations), Oncology (538 citations), Cancer Research (261 citations), Immunology (245 citations) and Molecular Biology (744 citations). Ehsan Malek has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include James J. Driscoll, Sajjeev Jagannathan, James J. Ignatz-Hoover, Byung‐Gyu Kim, Sung Hee Choi, Marcos de Lima, Muthulekha Swamydas, Nikhil Vad, Kenneth C. Anderson and James H. Finke. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Oncotarget and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.